Search

Your search keyword '"Verny, Christophe"' showing total 464 results

Search Constraints

Start Over You searched for: Author "Verny, Christophe" Remove constraint Author: "Verny, Christophe"
464 results on '"Verny, Christophe"'

Search Results

52. Clinical, neuropathological, and genetic characterization of STUB1 variants in cerebellar ataxias:a frequent cause of predominant cognitive impairment

53. Human Fetal Cell Therapy in Huntington's Disease: A Randomized, Multicenter, Phase II Trial

54. Assessing the experience of the quality of care of patients living with multiple sclerosis and their caregivers: The MusiCare questionnaire

55. MusiCare

57. Sensorineural hearing loss in OPA1-linked disorders

59. Estimation of the inbreeding coefficient through use of genomic data

64. STochastic Optical Reconstruction Microscopy (STORM) reveals the nanoscale organization of pathological aggregates in human brain

66. Novel CCM2 missense variants abrogating the CCM1–CCM2 interaction cause cerebral cavernous malformations

68. Reduced Cancer Incidence in Huntington's Disease: Analysis in the Registry Study

69. Efficacy of exome-targeted capture sequencing to detect mutations in known cerebellar ataxia genes

75. OPA1 mutations induce mitochondrial DNA instability and optic atrophy ‘plus’ phenotypes

76. Is multidetector CT-scan able to detect T3a renal tumor before surgery?

77. A Case of Type I Sialidosis With Osteonecrosis Revealing a New Mutation in NEU1

78. Biallelic MYORG mutation carriers exhibit primary brain calcification with a distinct phenotype

79. Phenotype associated with APP duplication in five families

80. Isolated Hornerʼs Syndrome May Herald Stroke

83. Cognitive decline in Huntington's disease expansion gene carriers

85. International Guidelines for the Treatment of Huntington's Disease

87. Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study

88. A locus-specific database for mutations in GDAP1 allows analysis of genotype-phenotype correlations in Charcot-Marie-Tooth diseases type 4A and 2K

89. Idebenone increases mitochondrial complex I activity in fibroblasts from LHON patients while producing contradictory effects on respiration

90. A randomized, double-blind, placebo-controlled trial evaluating cysteamine in Huntington's disease

91. Specific cognitive theory of mind and behavioral dysfunctions in early manifest Huntington disease: a case report.

92. A Metabolomics Profiling of Glaucoma Points to Mitochondrial Dysfunction, Senescence, and Polyamines Deficiency

94. A Plasma Metabolomic Signature of the Exfoliation Syndrome Involves Amino Acids, Acylcarnitines, and Polyamines

95. Primary fibroblasts derived from sporadic amyotrophic lateral sclerosis patients do not show ALS cytological lesions

96. A Plasma Metabolomic Signature Involving Purine Metabolism in Human Optic Atrophy 1 (OPA1)-Related Disorders

97. Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study

98. Guidelines for clinical pharmacological practices in Huntington's disease

99. Insulin-Like Growth Factor-1 but Not Insulin Predicts Cognitive Decline in Huntington's Disease

100. Neurotoxicity of Insecticides

Catalog

Books, media, physical & digital resources